Habilecare Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 8 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 28.03%
- Profit Growth -39.33%
- Ebitda -482.82%
- Net Worth 26.59%
- Total Assets 67.67%
About Habilecare Pharma
Habilecare Pharma Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 2019 (Six years 8 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ankit Mangal and Priyanka Vishnoi serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230RJ2019PTC063902
-
Company No.
063902
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
What products or services does Habilecare Pharma Private Limited offer?
Habilecare Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Hand Sanitizers & Personal Hygiene, Sanitary Pad, Sexual Wellness Products, Female Hygiene Products & Test Kits, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Erectile Dysfunction Medicine, Child and Baby Care Products.
Who are the key members and board of directors at Habilecare Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Vishnoi
|
Director | 06-Feb-2019 | Current |
|
Ankit Mangal
|
Director | 06-Feb-2019 | Current |
Financial Performance of Habilecare Pharma.
Habilecare Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.03% increase. The company also saw a substantial fall in profitability, with a 39.33% decrease in profit. The company's net worth Soared by an impressive increase of 26.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Habilecare Pharma?
Unlock access to Habilecare Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Habilecare Pharma?
Unlock and access historical data on people associated with Habilecare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Habilecare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Habilecare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.